Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure

NCT00799435 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Inability to recruit adequate Sample Size who met the entry criteria

Conditions

Diabetes Mellitus, Type 2
Heart Failure, Diastolic

Interventions

DRUG: Exenatide

Sponsor

Baylor College of Medicine

Collaborators

[object Object]